The National Cancer Institute (INCA) has indicated that more than 62,000 prostate cancer cases have been diagnosed in Brazil in 2018, behind only one non-melanoma melanoma. The rate of growth coincides with the evolution of the diagnostic tests, especially in the case of more information on the disease and prevention methods, such as those carried out in November.
According to Jonathan Luiz Pereira, the Urology Institute of the Paraná (UTI), due to the aging of men, new cases must appear. "We know that age is the main risk factor for prostate cancer. We have the recommendation of the Brazilian Urology Association, the prostate tumors starting from the age of 50 men with no risk factor and 45 years of age with the family history of father, siblings or marital illnesses. He needs more attention, because Afrodesecond is also a risk factor, "says the expert.
In the initial phase, the prostate tumor is asymptomatic, that is to say, it does not have symptoms. When some signs appear, such as bone loss and weight loss, 95% of tumors are already in the advanced stage, making it difficult to cure the cure. For this reason, it is essential to maintain regular examinations. "We are currently examining the PSA (Prostate Specific Antigen), as well as conducting a rectal study, if we make changes, we will investigate." A definitive diagnosis is carried out through the ultrasonography-driven biopsy. Thanks to the fusion, we put resonance and ultrasound images that can be talked about by the healing of ailment. We can talk about the healing of the disease, but in advanced cases, we have metastasic control of the disease. "he gave urology.
The selection of appropriate treatments depends on certain aspects, such as patient's health status, illness and life expectancy. "In the initial cases, signs of surgery, radiotherapy, hormone therapy or not, and in some cases, can be an active surveillance, as low-risk tumors continue to be very close, in the United States, for example, a highly available technique, It is about 90. Everyone should be aware of the ability to maintain the habit of consultation with the urologist, the physician evaluating the patient's evaluation periodically, the PSA's curve results and the physical examination of the prostate, all the types of prevention must follow the routine, "says Jonatas Luiz Perei.
Robotic surgery: Robotic technique is as effective as a common vision. Access to the country is still limited, there are only 41 robots in Brazil. In Curitiba, robotic surgery is performed by the Erasto Gaertner Hospital.
Immunotherapy: It is the treatment used by the body defense system to attack cancer cells. The main goal of this therapy is to act in a faster way for the immune system to deal with the disease. Studies indicate that 60% of patients will use some types of immunotherapy for 2020. Other studies deal with chemotherapy with immunotherapy to enhance the results.
Genetic test: BRAC 1 and BRAC 2 genetic tests mainly include breast cancer and breast cancer and / or ovarian cancer in prostate cancer, for many generations. Study of the blood or salt collisions with the help of the new generation sequencing methodology (NGS). It is a modern, highly sensitive study that is able to read all the DNA bases of BRCA1 and BRCA2 in a single test. The whole process lasts 20 days until the report is released from the sample collection.
Hormone treatment: medications or surgery are used to regulate androgen production (male hormones) to develop prostate cancer patients.
Dino is a commercial content released by Terra and is not the responsibility of Terra